Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tubular injury triggers podocyte dysfunction by β-catenin–driven release of MMP-7
Roderick J. Tan, Yingjian Li, Brittney M. Rush, Débora Malta Cerqueira, Dong Zhou, Haiyan Fu, Jacqueline Ho, Donna Beer Stolz, Youhua Liu
Roderick J. Tan, Yingjian Li, Brittney M. Rush, Débora Malta Cerqueira, Dong Zhou, Haiyan Fu, Jacqueline Ho, Donna Beer Stolz, Youhua Liu
View: Text | PDF
Research Article Nephrology

Tubular injury triggers podocyte dysfunction by β-catenin–driven release of MMP-7

  • Text
  • PDF
Abstract

Proteinuric chronic kidney disease (CKD) remains a major health problem worldwide. While it is well established that the progression of primary glomerular disease induces tubulointerstitial lesions, how tubular injury triggers glomerular damage is poorly understood. We hypothesized that injured tubules secrete mediators that adversely affect glomerular health. To test this, we used conditional knockout mice with tubule-specific ablation of β-catenin (Ksp-β-cat–/–) and subjected them to chronic angiotensin II (Ang II) infusion or Adriamycin. Compared with control mice, Ksp-β-cat–/– mice were dramatically protected from proteinuria and glomerular damage. MMP-7, a downstream target of β-catenin, was upregulated in treated control mice, but this induction was blunted in the Ksp-β-cat–/– littermates. Incubation of isolated glomeruli with MMP-7 ex vivo led to nephrin depletion and impaired glomerular permeability. Furthermore, MMP-7 specifically and directly degraded nephrin in cultured glomeruli or cell-free systems, and this effect was dependent on its proteolytic activity. In vivo, expression or infusion of exogenous MMP-7 caused proteinuria, and genetic ablation of MMP-7 protected mice from Ang II–induced proteinuria and glomerular injury. Collectively, these results demonstrate that β-catenin–driven MMP-7 release from renal tubules promotes glomerular injury via direct degradation of the key slit diaphragm protein nephrin.

Authors

Roderick J. Tan, Yingjian Li, Brittney M. Rush, Débora Malta Cerqueira, Dong Zhou, Haiyan Fu, Jacqueline Ho, Donna Beer Stolz, Youhua Liu

×

Figure 8

MMP-7 mediates nephrin degradation in vitro.

Options: View larger image (or click on image) Download as PowerPoint
MMP-7 mediates nephrin degradation in vitro.
(A and B) HEK-293 cells wer...
(A and B) HEK-293 cells were transfected with nephrin expression vector for 48 hours, followed by incubation with MMP-7 (50 nM) for various periods of time (A) or with increasing amounts of MMP-7 for 60 minutes (B). (C) Nephrin from overexpressing cells was immunoprecipitated with anti-nephrin antibody, followed by various treatments as indicated. MMP-7 caused nephrin depletion, which was inhibited by MMP Inhibitor II. (D and E) Representative SDS-PAGE shows that MMP-7 degraded recombinant mouse nephrin protein. Purified mouse nephrin protein (2 μg) was incubated with 50 nM MMP-7 for 60 minutes. Truncated form of mouse nephrin corresponding to Gln37 to Thr1049 (~150 kDa in size) is used (E). Arrows in D indicate the degradation fragments of nephrin.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts